Prevalence of Hyperkalemia and Familial Hyperkalemic Hypertension in 5100 Patients Referred to a Tertiary Hypertension Unit.

cardiovascular diseases electrolytes hyperkalemia hypertension prevalence

Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
04 Sep 2024
Historique:
medline: 4 9 2024
pubmed: 4 9 2024
entrez: 4 9 2024
Statut: aheadofprint

Résumé

Hyperkalemia is a frequent electrolyte alteration whose prevalence varies widely, depending on the adopted cutoff, the setting (inpatients versus outpatients), and the characteristics of the study population. Familial hyperkalemic hypertension (FHH) is a rare cause of hypertension, hyperkalemia, and hyperchloremic metabolic acidosis. In this retrospective observational study, we investigated the prevalence of hyperkalemia (serum K Overall, 374 (7.3%) patients had hyperkalemia. This was associated with drugs known to increase K The identification of hyperkalemia in patients with hypertensive has prognostic implications. A timely diagnosis of FHH is important for effective management of hypertension, electrolyte imbalance correction with tailored treatment, and genetic counseling.

Sections du résumé

BACKGROUND UNASSIGNED
Hyperkalemia is a frequent electrolyte alteration whose prevalence varies widely, depending on the adopted cutoff, the setting (inpatients versus outpatients), and the characteristics of the study population. Familial hyperkalemic hypertension (FHH) is a rare cause of hypertension, hyperkalemia, and hyperchloremic metabolic acidosis.
METHODS UNASSIGNED
In this retrospective observational study, we investigated the prevalence of hyperkalemia (serum K
RESULTS UNASSIGNED
Overall, 374 (7.3%) patients had hyperkalemia. This was associated with drugs known to increase K
CONCLUSIONS UNASSIGNED
The identification of hyperkalemia in patients with hypertensive has prognostic implications. A timely diagnosis of FHH is important for effective management of hypertension, electrolyte imbalance correction with tailored treatment, and genetic counseling.

Identifiants

DOI: 10.1161/HYPERTENSIONAHA.124.23500 PMID: 39229746
pubmed: 39229746
doi: 10.1161/HYPERTENSIONAHA.124.23500
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Martina Tetti (M)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy. (M.T., J.B., F.V., F.R., P.M., S.M.).

Jacopo Burrello (J)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy. (M.T., J.B., F.V., F.R., P.M., S.M.).
ORCID: 0000-0001-7884-7314

Marguerite Hureaux (M)

AP-HP, Département de Génétique et Centre de Référence des Maladies Rénales Rares, Hôpital Européen Georges Pompidou, Paris, France (M.H., C.B., E.C., X.J.).
Université Paris Cité, INSERM U970 Paris Cardiovascular Research Center, France (M.H., C.B., E.C., X.J.).

Clarisse Billon (C)

AP-HP, Département de Génétique et Centre de Référence des Maladies Rénales Rares, Hôpital Européen Georges Pompidou, Paris, France (M.H., C.B., E.C., X.J.).
Université Paris Cité, INSERM U970 Paris Cardiovascular Research Center, France (M.H., C.B., E.C., X.J.).

Eric Clauser (E)

AP-HP, Département de Génétique et Centre de Référence des Maladies Rénales Rares, Hôpital Européen Georges Pompidou, Paris, France (M.H., C.B., E.C., X.J.).
Université Paris Cité, INSERM U970 Paris Cardiovascular Research Center, France (M.H., C.B., E.C., X.J.).
ORCID: 0000-0003-1535-869X

Franco Veglio (F)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy. (M.T., J.B., F.V., F.R., P.M., S.M.).

Franco Rabbia (F)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy. (M.T., J.B., F.V., F.R., P.M., S.M.).

Barbara Pasini (B)

Department of Medical Science, University of Torino, Italy. (B.P.).
SC Genetica Medica U, AOU Città della Salute e della Scienza di Torino, Italy (B.P.).
ORCID: 0000-0002-4373-1212

Annalisa Crisetti (A)

Nephrology and Dialisis Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy (A.C.).

Xavier Jeunemaitre (X)

AP-HP, Département de Génétique et Centre de Référence des Maladies Rénales Rares, Hôpital Européen Georges Pompidou, Paris, France (M.H., C.B., E.C., X.J.).
Université Paris Cité, INSERM U970 Paris Cardiovascular Research Center, France (M.H., C.B., E.C., X.J.).

Paolo Mulatero (P)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy. (M.T., J.B., F.V., F.R., P.M., S.M.).
ORCID: 0000-0002-5480-1116

Silvia Monticone (S)

Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Torino, Italy. (M.T., J.B., F.V., F.R., P.M., S.M.).
ORCID: 0000-0002-7322-2005

Classifications MeSH